A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives



Status:Archived
Conditions:Women's Studies
Therapuetic Areas:Reproductive
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:January 2011
End Date:September 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Multicenter, Open-label Study to Evaluate Ovarian Follicular Activity and Hormone Levels With the Oral Contraceptive Regimen DR-102 Compared to Two 28-day Oral Contraceptive Regimens Containing Different Synthetic Progestins


This study is being conducted to evaluate the impact of a 28-day oral contraceptive compared
to two 28-day oral contraceptive regimens containing different synthetic progestins on
ovarian follicular activity and hormone levels in healthy women.



We found this trial at
2
sites
Teva Investigational Site
Seattle, Washington 98105
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Teva Investigational Site
Uniontown, Pennsylvania 15401
174
mi
from 43215
Uniontown, PA
Click here to add this to my saved trials